Among the ALK transforming mutations reported in neuroblastomas, mutations at kinase domain residues F1174 and R1275 are the most frequently reported [34], [35], and cells harboring these mutations have been shown to be sensitive to small molecule inhibitors of ALK in vitro[35], [41]. Here, ALK is linked to neuroblastoma.